Edition:
India

ESSA Pharma Inc (EPIX.OQ)

EPIX.OQ on NASDAQ Stock Exchange Capital Market

2.86USD
20 Sep 2019
Change (% chg)

$-0.19 (-6.23%)
Prev Close
$3.05
Open
$2.90
Day's High
$3.00
Day's Low
$2.82
Volume
29,271
Avg. Vol
9,242
52-wk High
$4.45
52-wk Low
$1.41

Latest Key Developments (Source: Significant Developments)

Realm Therapeutics Provides Update On Company’S Nasdaq Listing
Friday, 19 Jul 2019 

July 19 (Reuters) - Realm Therapeutics PLC ::REALM THERAPEUTICS PLC - REALM THERAPEUTICS PLC UPDATE ON COMPANY’S NASDAQ LISTING.REALM THERAPEUTICS - RECEIVED NOTICE THAT NASDAQ HEARINGS PANEL GRANTED CO'S REQUEST FOR AN EXTENSION TO CONTINUE LISTING OF COMPANY'S ADSS ON NASDAQ.REALM THERAPEUTICS - EXTENSION CONDITIONAL UPON PROPOSED DEAL WITH ESSA PHARMA INC BEING COMPLETED ON OR BEFORE 31 JULY 2019.REALM THERAPEUTICS - BEEN INFORMED IF DEAL NOT COMPLETED ON/BEFORE 31 JULY 2019, PANEL TO ISSUE A DELISTING NOTIFICATION&SUSPEND TRADING OF CO'S ADSS.  Full Article

Eventide Asset Management Reports 17.4% Stake In Essa Pharma As Of June 30
Monday, 15 Jul 2019 

July 15 (Reuters) - :EVENTIDE ASSET MANAGEMENT - ACQUIRED ESSA PHARMA SHARES FOR INVESTMENT PURPOSES - SEC FILING.EVENTIDE ASSET MANAGEMENT - ENGAGED IN DISCUSSIONS WITH MANAGEMENT OF ESSA PHARMA.EVENTIDE ASSET MANAGEMENT - REPORTS 17.4% STAKE IN ESSA PHARMA AS OF JUNE 30.EVENTIDE ASSET MANAGEMENT LLC -HAD PREVIOUSLY REPORTED 19.2% STAKE IN ESSA PHARMA INC AS OF MAY 14.  Full Article

Essa Pharma Inc - QTRLY Loss Per Share $0.42
Friday, 8 Feb 2019 

ESSA Pharma Inc ::ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS FINANCIAL RESULTS FOR FISCAL FIRST QUARTER ENDED DECEMBER 31, 2018.ESSA PHARMA INC - QTRLY LOSS PER SHARE $0.42.  Full Article

Essa Pharma provides corporate update and reports financial results for fiscal fourth quarter
Friday, 14 Dec 2018 

Dec 13 (Reuters) - ESSA Pharma Inc ::ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS FINANCIAL RESULTS FOR FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2018.ESSA PHARMA INC - QTRLY LOSS PER COMMON SHARE $0.39.  Full Article

Essa Pharma Qtrly Loss Per Share $0.50
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - ESSA Pharma Inc ::ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS FINANCIAL RESULTS FOR FISCAL THIRD QUARTER ENDED JUNE 30, 2018.ESSA PHARMA INC - QTRLY LOSS PER COMMON SHARE $0.50.  Full Article

Essa Pharma Files For Offering Of About 113.9 Million Common Shares That May Be Offered For Resale By Selling Shareholders
Tuesday, 23 Jan 2018 

Jan 22 (Reuters) - Essa Pharma Inc ::ESSA PHARMA INC FILES FOR OFFERING OF ABOUT 113.9 MILLION COMMON SHARES THAT MAY BE OFFERED FOR RESALE BY SELLING SHAREHOLDERS - SEC FILING.  Full Article

Essa Says Intends To Issue Up To 125 Mln Common Shares At $0.20 Per Share
Wednesday, 3 Jan 2018 

Jan 2 (Reuters) - Essa Pharma Inc ::ESSA ANNOUNCES FILING OF AMENDED AND RESTATED PROSPECTUS SUPPLEMENT AND AN UPDATE TO PREVIOUSLY ANNOUNCED EQUITY OFFERING.ESSA PHARMA - INTENDS TO ISSUE UP TO 125,000,000 COMMON SHARES AT A PRICE OF US$0.20 PER COMMON SHARE FOR AGGREGATE GROSS PROCEEDS OF UP TO US$25 MILLION.  Full Article

Essa Pharma Announces Pricing Of Previously Announced Equity Offering
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Essa Pharma Inc ::ESSA PHARMA ANNOUNCES PRICING OF PREVIOUSLY ANNOUNCED EQUITY OFFERING.ESSA PHARMA INC - ‍ESSA INTENDS TO ISSUE COMMON SHARES IN CAPITAL OF COMPANY AT A PRICE OF US$0.20 PER COMMON SHARE.  Full Article

ESSA Pharma announces overnight marketed equity offering
Wednesday, 13 Dec 2017 

Dec 12 (Reuters) - Essa Pharma Inc ::ESSA PHARMA ANNOUNCES OVERNIGHT MARKETED EQUITY OFFERING.ESSA PHARMA - TO USE NET PROCEEDS OF OFFERING PRIMARILY TO CONTINUE ONGOING PRECLINICAL DEVELOPMENT OF CO'S ANITEN COMPOUNDS.  Full Article

Essa Pharma Reports Qtrly Loss Per Share Of $0.07
Tuesday, 12 Dec 2017 

Dec 11 (Reuters) - ESSA Pharma Inc ::ESSA PHARMA ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2017.QTRLY BASIC AND DILUTED LOSS PER COMMON SHARE $0.07‍​.‍CASH ON HAND AS AT SEPTEMBER 30, 2017 WAS $3.98 MILLION, WITH WORKING CAPITAL OF $1.28 MILLION​.  Full Article